Global Platelet Aggregation Devices Market 2017-2021
About Platelet Aggregation Devices
Platelet aggregation devices are used for diagnosis of inherited and acquired bleeding disorders and for monitoring anti-platelet therapies. The platelet aggregative devices market includes systems or instruments, reagents, and accessories and consumables used in platelet function testing. Platelet aggregation is a biological process where the platelet cells are involved in hemostasis. Hemostasis is a process of prevention of bleeding via vasoconstriction, rapid formation of a platelet plug, and clot formation.
Technavio’s analysts forecast the global platelet aggregation devices market to grow at a CAGR of 17.02% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global platelet aggregation devices market for 2017-2021. To calculate the market size, the report considers sales, volume, value, and spares market.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Platelet Aggregation Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global platelet aggregation devices market: F. Hoffmann-La Roche, Haemonetics, Helena Laboratories, Instrumentation Laboratory, and Siemens Healthineers.
Other Prominent Vendors in the market are: AggreDYNE, Bio/Data Corporation, Chrono-log Corporation, Drucker Diagnostics, LAbor BioMedical Technologies (LaBiTec), Matis Medical, Sentinel Diagnostics, and Sysmex Corporation.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increase in industry-academia collaborations. There is an increasing trend of academic and industry partnerships for R&D of pharmaceuticals and medical devices. This will provide mutual benefits to both academic institutes and industries. For academic institutions, these collaborations help in the commercialization of their discoveries from basic research into medical products.”
According to the report, one driver in the market is growing number of surgical procedures. The number of surgeries is rapidly increasing in both developed and developing countries due to the rapidly growing aging population. About 60-70 million inpatient and outpatient surgeries are performed every year in the US. Coronary artery bypass graft (CABG) surgery is one of the most frequently performed surgeries in the US. It is estimated that more than 500,000 CABG procedures are performed in the US every year. More than five million orthopedic surgeries are performed globally every year.
Further, the report states that one challenge in the market is high cost of the devices. The shift from traditional diagnostic tests to highly automated procedures has increased the demand for more flexible platelet aggregation devices, which are equipped with the advanced detector and sensor systems. The specialized platelet aggregometer are very expensive. The advanced platelet aggregometer cost between $10,000 and $20,000 based on the features offered. The cost will further increase with associated reagents, accessories and consumables expenses, and maintenance charges.
F. Hoffmann-La Roche, Haemonetics, Helena Laboratories, Instrumentation Laboratory, Siemens Healthineers, AggreDYNE, Bio/Data Corporation, Chrono-log Corporation, Drucker Diagnostics, LAbor BioMedical Technologies (LaBiTec), Matis Medical, Sentinel Diagnostics, and Sysmex Corporation.